OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
603039 Weaver Network Technology
- 65.67
- -1.50-2.23%
Market Closed Apr 1 15:00 CST
17.11BMarket Cap84.30P/E (TTM)
67.75High65.40Low29.43KlotVolume66.31Open67.17Pre Close194.67MTurnover1.13%Turnover Ratio84.30P/E (Static)260.60MShares85.1852wk High7.92P/B17.11BFloat Cap26.2952wk Low73.89Limit Up260.60MShs Float93.07Historical High60.45Limit Down3.50%Amplitude4.95Historical Low0.23Dividend TTM66.15Avg Price14.28KlotAsk0.34%Div YieldTTM100Lot Size12.47KlotBid
Weaver Network Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.31%2.36B | -0.87%1.39B | -2.16%885.68M | 3.13%343.35M | 2.65%2.39B | 3.95%1.4B | 14.72%905.24M | 13.62%332.92M | 16.41%2.33B | 18.66%1.34B |
| Operating revenue | -1.31%2.36B | -0.87%1.39B | -2.16%885.68M | 3.13%343.35M | 2.65%2.39B | 3.95%1.4B | 14.72%905.24M | 13.62%332.92M | 16.41%2.33B | 18.66%1.34B |
| Other operating revenue | --1.27M | ---- | --284.61K | ---- | --0 | ---- | --0 | ---- | 2,871.52%94.85M | ---- |
| Total operating cost | -3.51%2.15B | -6.41%1.31B | -4.33%842.39M | -3.07%328.59M | 4.70%2.23B | 13.47%1.4B | 19.90%880.48M | 18.38%338.99M | 20.73%2.13B | 20.09%1.24B |
| Operating cost | 9.92%159.52M | 11.40%95.94M | 0.01%56.44M | 5.47%20.35M | -8.06%145.13M | -21.63%86.12M | 32.27%56.43M | 21.41%19.29M | 73.81%157.85M | 118.03%109.89M |
| Operating tax surcharges | 4.19%16.79M | -2.77%9.14M | -3.32%5.42M | 9.51%2.3M | -8.18%16.11M | -7.73%9.4M | -8.01%5.6M | -21.75%2.1M | 34.33%17.55M | 60.65%10.19M |
| Operating expense | -3.25%1.61B | -3.08%944.13M | -2.64%606.05M | -1.84%226.73M | 5.48%1.67B | 12.47%974.17M | 16.32%622.47M | 19.74%230.97M | 14.56%1.58B | 13.07%866.18M |
| Administration expense | -16.63%73.02M | -45.59%52.79M | -6.64%36.98M | 12.00%15.95M | 27.58%87.59M | 74.84%97.02M | 23.96%39.61M | -33.25%14.25M | -24.63%68.65M | -13.30%55.49M |
| Financial expense | 12.33%-34M | 13.83%-25.11M | 7.13%-17.55M | 3.87%-8.93M | -16.84%-38.78M | 19.84%-29.14M | 22.96%-18.9M | 32.58%-9.29M | 37.17%-33.2M | 1.20%-36.35M |
| -Interest expense (Financial expense) | -12.31%339.42K | -14.93%259.44K | -21.96%166.79K | -30.53%80.37K | -28.19%387.05K | -25.25%304.97K | -23.27%213.73K | -32.07%115.68K | 134.00%539.01K | -74.94%407.99K |
| -Interest Income (Financial expense) | 13.49%-34.23M | 12.78%-25.76M | 8.82%-17.5M | 6.65%-8.89M | -16.43%-39.57M | 19.52%-29.54M | 22.69%-19.19M | 31.82%-9.53M | 33.84%-33.98M | 4.56%-36.7M |
| Research and development | -8.34%324.71M | -11.04%235.68M | -11.53%155.05M | -11.61%72.2M | 4.23%354.27M | 14.89%264.93M | 22.53%175.26M | 21.28%81.68M | 39.53%339.89M | 28.64%230.6M |
| Credit Impairment Loss | -53.54%-17.13M | -62.95%-3.79M | -3,292.15%-2.35M | -28.01%1.85M | 14.61%-11.16M | 68.12%-2.33M | 101.70%73.68K | 3,202.73%2.57M | 3.46%-13.07M | -1.16%-7.3M |
| Asset Impairment Loss | -1,699.87%-26.58M | 231.55%378.27K | 141.14%114.12K | 219.60%443.79K | -136.04%-1.48M | -279.57%-287.56K | -191.62%-277.39K | -67.18%138.86K | 2.38%-625.75K | 179.51%160.14K |
| Other net revenue | -186.91%-3.46M | 411.66%10.65M | 66.95%4.37M | 73.26%12.06M | -83.10%3.98M | -65.13%2.08M | -12.31%2.62M | -22.23%6.96M | -73.75%23.53M | -90.87%5.97M |
| Invest income | 52.18%-21.31M | 26.97%-28.39M | 17.94%-20.4M | -1.92%-9.33M | -7.37%-44.57M | -3.79%-38.88M | -13.12%-24.86M | -34.48%-9.15M | -478.61%-41.51M | -389.32%-37.46M |
| -Including: Investment income associates | 28.32%-41.72M | 11.92%-42.55M | 0.98%-30.97M | -14.38%-14.85M | -10.31%-58.2M | -25.39%-48.31M | -38.85%-31.27M | -84.86%-12.98M | -108.05%-52.76M | -66.66%-38.53M |
| Asset deal income | 5,941.74%107.07K | -350.29%-3.5K | -118.87%-3.29K | -116.24%-2.83K | -100.91%-1.83K | -27.43%1.4K | --17.42K | --17.42K | -98.83%200.35K | -99.99%1.93K |
| Other revenue | 0.47%61.46M | -2.56%42.46M | -2.35%27.01M | 42.66%19.1M | -22.09%61.18M | -13.82%43.58M | -4.60%27.66M | -12.24%13.39M | 3.73%78.53M | 16.74%50.57M |
| Operating profit | 23.97%204.92M | 3,082.46%83.56M | 74.10%47.67M | 2,934.78%26.81M | -26.01%165.3M | -102.45%-2.8M | -52.55%27.38M | -94.33%883.57K | -31.66%223.4M | -32.39%114.44M |
| Add:Non operating Income | 13.59%8.64M | -72.33%1.71M | -50.68%1.71M | 928.04%1.71M | -26.97%7.6M | -19.46%6.18M | -27.78%3.46M | 44.02%166.2K | 24.55%10.41M | 1.20%7.67M |
| Less:Non operating expense | 136.63%212.47K | 33.20%109.26K | -90.13%7.54K | -98.37%594.6 | -25.75%89.79K | 153.51%82.03K | 166.45%76.37K | 28.15%36.37K | -55.06%120.93K | -65.04%32.36K |
| Total profit | 23.46%213.35M | 2,486.93%85.16M | 60.45%49.37M | 2,714.54%28.52M | -26.05%172.81M | -97.30%3.29M | -50.75%30.77M | -93.54%1.01M | -30.24%233.69M | -30.93%122.08M |
| Less:Income tax cost | 277.17%10.4M | 86.88%-1.06M | 124.56%1.92M | 20.54%527.83K | -156.71%-5.87M | -427.27%-8.09M | 6.57%-7.81M | -20.46%437.9K | -60.59%10.35M | -116.29%-1.53M |
| Net profit | 13.58%202.94M | 657.69%86.23M | 22.99%47.45M | 4,764.41%27.99M | -19.99%178.68M | -90.79%11.38M | -45.53%38.58M | -96.20%575.5K | -27.65%223.34M | -26.13%123.61M |
| Net profit from continuing operation | 13.58%202.94M | 657.69%86.23M | 22.99%47.45M | 4,764.41%27.99M | -19.99%178.68M | -90.79%11.38M | -45.53%38.58M | -96.20%575.5K | -27.65%223.34M | -26.13%123.61M |
| Net profit of parent company owners | 13.58%202.94M | 657.69%86.23M | 22.99%47.45M | 4,764.41%27.99M | -19.99%178.68M | -90.79%11.38M | -45.53%38.58M | -96.20%575.5K | -27.65%223.34M | -26.13%123.61M |
| Earning per share | ||||||||||
| Basic earning per share | 13.04%0.78 | 750.00%0.34 | 26.67%0.19 | --0.11 | -19.77%0.69 | -91.67%0.04 | -44.44%0.15 | --0 | -28.33%0.86 | -26.15%0.48 |
| Diluted earning per share | 13.04%0.78 | 750.00%0.34 | 26.67%0.19 | --0.11 | -19.77%0.69 | -91.67%0.04 | -44.44%0.15 | --0 | -28.33%0.86 | -25.00%0.48 |
| Other composite income | -185.94%-167.15K | 120.30%149.65K | -332.81%-384.67K | -6,729.97%-273.11K | -31.51%194.49K | -69.60%67.93K | 157.51%165.23K | -528.08%-4K | 2,910.52%283.96K | 3,309.58%223.48K |
| Other composite income of parent company owners | -185.94%-167.15K | 120.30%149.65K | -332.81%-384.67K | -6,729.97%-273.11K | -31.51%194.49K | -69.60%67.93K | 157.51%165.23K | -528.08%-4K | 2,910.52%283.96K | 3,309.58%223.48K |
| Total composite income | 13.36%202.78M | 654.50%86.38M | 21.47%47.06M | 4,750.66%27.72M | -20.01%178.88M | -90.76%11.45M | -45.35%38.74M | -96.22%571.5K | -27.56%223.62M | -25.99%123.83M |
| Total composite income of parent company owners | 13.36%202.78M | 654.50%86.38M | 21.47%47.06M | 4,750.66%27.72M | -20.01%178.88M | -90.76%11.45M | -45.35%38.74M | -96.22%571.5K | -27.56%223.62M | -25.99%123.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.